# Divalproex Sodium

NDC: 0832-7122
Generic name: Divalproex Sodium
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20140321
Marketing ended: 20271031
FDA application: ANDA078182

## Active ingredients

- DIVALPROEX SODIUM: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0832-7122"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0832-7122
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02304a23-4a5f-47bc-9687-4044b43f7a20